Immunostimulatory sutures that treat local disease recurrence following primary tumor resection

Janjira Intra, Xue Qing Zhang, Robin L. Williams, Xiaoyan Zhu, Anthony D. Sandler, Aliasger K. Salem

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


Neuroblastoma is a common childhood cancer that often results in progressive minimal residual disease after primary tumor resection. Cytosine-phosphorothioate-guanine oligonucleotides (CpG ODN) have been reported to induce potent anti-tumor immune responses. In this communication, we report on the development of a CpG ODN-loaded suture that can close up the wound following tumor excision and provide sustained localized delivery of CpG ODN to treat local disease recurrence. The suture was prepared by melt extruding a mixture of polylactic acid-co-glycolic acid (PLGA 75:25 0.47 dL g-1) pellets and CpG ODN 1826. Scanning electron microscopy images showed that the sutures were free of defects and cracks. UV spectrophotometry measurements at 260 nm showed that sutures provide sustained release of CpG ODN over 35 days. Syngeneic female A/J mice were inoculated subcutaneously with 1 × 10 6 Neuro-2a murine neuroblastoma wild-type cells and tumors were grown between 5 to 10 mm before the tumors were excised. Wounds from the tumor resection were closed using CpG ODN-loaded sutures and/or polyglycolic acid Vicryl suture. Suppression of neuroblastoma recurrence and mouse survival were significantly higher in mice where wounds were closed using the CpG ODN-loaded sutures relative to all other groups.

Original languageEnglish (US)
Article number011001
JournalBiomedical Materials
Issue number1
StatePublished - Feb 2011


Dive into the research topics of 'Immunostimulatory sutures that treat local disease recurrence following primary tumor resection'. Together they form a unique fingerprint.

Cite this